Navigation Links
Bioprocessing Facilities 2011 Conference to be held Aug. 8-9 in San Diego
Date:3/8/2011

ORINDA, Calif., March 8, 2011 /PRNewswire/ -- Management teams specializing in facilities, systems, and equipment for R&D, scale-up and manufacturing of biologics (biopharmaceuticals, vaccines, biotherapeutics and biodiagnostics) will meet at the Bioprocessing Facilities 2011 Conference Aug. 8-9 at the Hilton San Diego Resort to examine best-in-class industry solutions.

The conference will detail management experience, lessons learned, findings, and insights on cGMP bioprocessing facilities including new plans for reduced capital and operating costs; successful models for people and materials flow; implementation strategies for modular and disposable technologies; capacity planning approaches for mixed-use, multiproduct facilities; plans that maximize flexibility and speed to market; advances in MEP and processing equipment and more.

Speakers will include representatives from Fraunhofer USA, on their first-of-its-kind cGMP facility for plant-based protein production that does not require large-scale culturing or fermentation processes; Statens Serum Institute of Copenhagen, Denmark, an international research, production and service enterprise involved in vaccine and biologics development and diagnostic services; and Texas A&M's 155,000-sf National Center for Therapeutics Manufacturing (NCTM), which has the capacity for developing and producing multiple biological products using multiple production technologies.

For more information about Bioprocessing Facilities 2011, visit http://www.TradelineInc.com/Bioprocessing2011.

About Tradeline, Inc.

Tradeline, Inc. produces an annual series of conferences on leading-edge planning, design, and construction of facilities as well as the management of facilities portfolios and workplace support services. Tradeline is also an Internet publisher of breaking news, special reports, webcasts, and other resources enabling facilities professionals to make better investment and operating decisions for the future of their respective institutions.

For more information about Tradeline, visit http://www.TradelineInc.com.

Media contact: Bill Nothofer, Tradeline, Inc., (925) 254-1744, ext. 19; bnothofer@tradelineinc.com.


'/>"/>
SOURCE Tradeline, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Frontiers in Carbohydrates Developments: Report 4; Research, Technologies; Biotechnology, Bioprocessing & Bioplastics - Food & Industrial Raw Material, January 2011
2. BioNeutrals Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World
3. Covanta Announces Amended Terms for its Acquisition of Two Biomass Energy Facilities in Maine
4. AARC Presentation Cites Masimo Patient SafetyNet as Key Factor in Improving Patient Outcomes and Reducing Costs in Post-Acute Care Facilities
5. Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities
6. VeraSun Energy Selects Valero as Successful Bidder for Seven Facilities
7. NIH News Confirms Trend in Stem Cell Storage Facilities, says CEO of San Diego-based Bio-Matrix Scientific Group
8. Peptimmune to Collaborate on Dengue Virus Vaccine and Point-Of-Care Diagnostic With Two DOD Biomedical Research Facilities
9. All TT Electronics Integrated Manufacturing Services Facilities Accredited with Medical Manufacturing Standard
10. Epeius Biotechnologies Corporation Expands its Rexin-G Production Facilities in Southern California
11. MedShape Solutions, Inc. Announces Commercialization of SBIR Funded Technology: Receives Purchasing Preference in Federally Funded Hospitals and Health Care Facilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 19, 2017 /PRNewswire -- WuXi AppTec, a leading ... and technology platform, today announced that it has ... preclinical drug discovery contract research organization (CRO). After ... wholly-owned subsidiary of WuXi, and will continue to ... greater services. The acquisition will further strengthen WuXi,s ...
(Date:1/19/2017)... , ... January 19, 2017 ... ... advanced software solutions for pharmaceutical research and development (R&D), today announced the ... omic data analysis and interpretation for the rapidly evolving field of precision ...
(Date:1/19/2017)... GAITHERSBURG, Md. , Jan. 19, 2017 ... Inc., a privately-held immunotherapeutics company targeting infectious diseases, ... for the merger of PharmAthene and Altimmune in ... Venture Fund, HealthCap, Truffle Capital and Redmont Capital. ... diversified immunotherapeutics company with four clinical stage and ...
(Date:1/19/2017)... 2017 AquaBounty Technologies, Inc. (AIM: ABTU; NASDAQ: ... aquaculture and a majority-owned subsidiary of Intrexon Corporation (NYSE: ... the listing of its common shares on the NASDAQ ... "AquaBounty,s listing on NASDAQ represents an important ... to the U.S. markets as we advance plans for ...
Breaking Biology Technology:
(Date:1/6/2017)... Calif. , Jan. 5, 2017  Delta ID ... its iris scanning technology for automotive at CES® 2017. ... GNTX ) to demonstrate the use of iris ... identify and authenticate the driver in a car, and ... during the driving experience. Delta ID and ...
(Date:12/22/2016)... -- As part of its longstanding mission to improve genetic literacy ... released its latest children,s book, titled The One ... topics of inheritance and variation of traits that are part ... school classrooms in the US. The book ... Killoran , whose previous book with 23andMe, You ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic Biomedicals ... el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera ... en 2017, con múltiples sitios previstos a lo largo de Europa ... MSC-1 ... factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa ...
Breaking Biology News(10 mins):